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the treatment of contained ruptured abdominal
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Purpose: Food and Drug Administration–approved endografts are suitable for the elective repair of abdominal aortic
aneurysms (AAAs) with favorable aneurysm anatomy. Our aim is to illustrate the feasibility and versatility of commer-
cially available endografts for emergency AAA repair in hemodynamically stable AAA rupture.
Methods: From June 2001 to July 2002, five patients presented with severe abdominal pain and were diagnosed with
contained rupture of an infrarenal AAA. In all cases, patients were deemed unfit to withstand conventional open repair
by both the referring outside medical center as well as our center’s team. All patients were hemodynamically stable on
arrival at our medical center. Measurement and selection of endovascular devices were based on computed tomography
(CT) scans performed emergently at the outside referring center. The required emergently procured endografts were
obtained within 2 to 4.5 hours (mean, 3.1 hours) of presentation. Complex anatomy at the proximal and distal fixation
zones or difficult access was present in every case.
Results: All patients survived endograft repair and had successful exclusion of their aneurysm sac on the basis of
intraoperative arteriography and postoperative CT surveillance. All were discharged to home at baseline function within
a mean of 6.8 days (range, 2-13 days). There were no deaths. There was one postoperative pulmonary embolism, one
myocardial infarct, and one type 2 endoleak. Mean operative time and blood loss were 4.67 hours and 217 mL,
respectively. At a mean follow-up of 18 months, CT scans showed stable or shrinking aneurysm sacs.
Conclusions: In patients with contained ruptured AAAs who present with hemodynamic stability and comorbidities that
preclude open surgery, commercially available endografts are a versatile treatment option even in the face of complicated
aneurysm anatomy. (J Vasc Surg 2004;40:154-60.)During the last 10 years with the introduction of endo-
vascular technology, elective abdominal aortic aneurysm
(AAA) repair evolved to a minimally invasive approach.
Emergency presentations, however, continue to be mostly
treated by standard open repair. Although some authors
remain skeptical regarding the long-term results of endovas-
cular AAA exclusion,1,2 endovascular repair has been reported
to have improved postoperative morbidity and mortality.3,4
Emergency open AAA repair for rupture is associated
with high morbidity and mortality. The utility of the endo-
vascular approach for emergency AAA presentations has
been explored at a limited number of centers, usually with
surgeon-made endografts. Usually the conditions of urgent
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doi:10.1016/j.jvs.2004.02.042154aneurysm repair preclude the required detailed imaging and
measurements for endograft design. In addition, commer-
cial procurement of the designed endograft might take too
long to meet the needs of an emergency AAA presentation.
These devices are extremely costly and are not supplied by
consignment; therefore most centers do not carry “on-the-
shelf” inventory in their operating rooms. Some groups
have introduced their own “one-size-fits-most” custom-
made endograft design for ruptured AAAs with great
promise.5,6 However, the majority of vascular surgeons
have access only to the commercially available devices ap-
proved by the Food and Drug Administration (FDA). In
the setting of an emergency presentation, the time needed
for endograft design and procurement would deter most
vascular surgeons from entertaining the endovascular ap-
proach as a treatment option.
We report a group of 5 patients with contained rup-
tured AAAs who were transferred to our medical center
from neighboring centers because their medical comorbid-
ity placed them at prohibitive morbidity/mortality rate
with open AAA repair. On medical assessment by our team
and concurrence that medical comorbidities were prohibi-
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FDA-approved endografts. These patients were all hemo-
dynamically stable on arrival at our medical center. In these
emergency settings, available imaging was usually less than
optimal, including noncontrast computed tomography
(CT) scans or thick-cut CT scans. However, although
commercially available endografts are certainly not “one-
size-fits-all,” these devices proved to be sufficiently versatile
to allow successful AAA exclusion in these emergency
presentations.
PATIENTS AND METHODS
From June 2001 to July 2003, 10 patients presented
with ruptured AAAs. Five of these patients presented to
outside medical centers with abdominal pain and were
found to have infrarenal AAA rupture by emergency de-
partment CT scans. All 5 patients were transferred to our
medical center for a second opinion, because open repair
was thought to be of prohibitive risk because of associated
medical comorbidities. They were all hemodynamically sta-
ble. Three of the 5 patients had been diagnosed with AAA
5 cm before presentation, 2 of whom had prohibitive
medical conditions for open repair, and the third patient
was in the midst of a cardiac evaluation expected to yield
evidence of prohibitive risk because of new-onset unstable
angina. The remaining 2 patients were first diagnosed with
AAA at the time of their rupture by CT scan in the emer-
gency department. Table I summarizes the pre-existing
medical comorbidities of all cases.
Endografts were expeditiously procured with any avail-
able imaging. The focus of the design was to determine the
outer-to-outer width of the aorta at the level of the renal
arteries and the outer-to-outer diameter of the distal left
and right common iliac arteries. As best as possible, the
extent of the aneurysm, calcification, and angulation were
estimated, and they influenced the endograft design. How-
ever, multiple potential designs were formulated in a plan
A, B, and C fashion.
Table I. Summary of key pre-existing severe advanced com
presentation
Patient A Patient B Pa
S/P MI (2 wk prior) COPD* COPD*
PBP, 118/62 mm Hg PBP, 134/76 mm Hg PBP, 110
CAD† CAD Disabling
S/P CVA CHF§ Carotid s
Severe aortic stenosis IDDM
PAD Renal insufficiency
Renal insufficiency
PBP, Presenting blood pressure; MI, myocardial infarct; COPD, chronic obs
CVA, cerebrovascular accident; IDDM, insulin-dependent diabetes mellitus
heart failure; S/P, status post.
*Oxygen-dependent at home.
†Non revascularizable unstable angina.
‡S/P irradiation treatment.
§Myocardial injection fraction  15%.The endografts were procured from both Guidant
(ANCURE; Indianapolis, Ind) and Medtronics (AneuRx;
Minneapolis, Minn). Clinical specialists from the respective
companies were contacted, and all components of the
potential designs were urgently requested. On the basis of
availability and estimated time of arrival, the operating
room was instructed to reserve a room in anticipation of an
endograft repair of a ruptured AAA. All patients were
informed of the uncertain nature of these procedures in the
acute setting and that waiting could prove fatal. However,
they were also informed that the likelihood of surviving an
open repair was very low, a medical assessment that had also
been given by an independent medical team before their
transfer to our medical center. One patient, who waited 24
hours for his repair, had family who were ambivalent about
providing further medical care, hence the delay in surgery.
This patient was admitted to a regular floor bed with a
do-not-resuscitate status. The remaining patients were all
sent to the preoperative holding area, in which they re-
ceived critical care from attending anesthesiologists, sur-
geons, and nursing. Patients were treated with intravenous
fluids, Foley catheters were placed, and blood pressure was
controlled with intravenous nitroglycerin for systolic blood
pressure of 80 to 100 mm Hg.
The usual instrument sets used for open repair and
endovascular repair were made available on the sterile field.
Imaging was performed with the OEC 9800 mobile C-
arm. Patients were brought to the operating room within 1
hour of the anticipated arrival of the endograft. Frequent
communication with the clinical specialists facilitated time
estimation.
Patients were prepped from the upper chest to the
knees and draped before induction of general anesthesia.
Patient B underwent local anesthesia with sedation,
whereas the other patients underwent general anesthesia.
Arteriography was first performed via left or right groin
puncture to delineate current anatomy and feasibility of
endograft deployment. This intraoperative imaging study
dities in patients treated and blood pressure on initial
C Patient D Patient E
NSC lung carcinoma Ongoing MI
mm Hg PBP, 133/70 mm Hg PBP, 142/68 mm Hg
Brain metastases‡ CAD†
is COPD
e pulmonary disease; DJD, degenerative joint disease; NSC, non–small cell;
, peripheral arterial disease; CAD, coronary artery disease; CHF, congestiveorbi
tient
/57
DJD
tenos
tructiv
; PAD
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there were no gross anatomic contraindications to endovas-
cular repair. A cutdown on both common femoral arteries
was made. A standard sequence (the same as for elective
cases) was followed for each endograft deployment. We
used full heparinization (100 U/kg) for these procedures
as close to deployment of the endograft as possible. Table II
summarizes the key anatomic measurements with focus
on endograft fixation zones. Details of the utilized de-
vices and design descriptions for each patient are listed in
Table III.
Patient B had particularly complex aneurysm anatomy
from the perspective of attempting endovascular treatment
(Figs 1 and 2). The left common iliac artery was chronically
occluded, and the right common iliac artery was aneurys-
mal. The left common iliac occlusion warranted a planned
conversion to an aorto–right uniiliac design. When using
Table II. Summary of key aortoiliac dimensions/features w
Anatomic factor Patient A P
Infrarenal neck diameter (mm) 25
Infrarenal neck length (mm) 12
AAA maximum diameter (mm) 85
Distal right CIA diameter (mm) 10 25 (E
Distal left CIA diameter (mm) 8 O
Right CIA calcification Moderate No (a
Left CIA calcification No No (o
Patency of hypogastric arteries Patent Right, occ
CIA, Common iliac artery; EIA, external iliac artery.
Fig 1. A, CT scan of ruptured AAA in patient B. B and C
from AAA in patient B. Left common iliac artery and rigthe AneuRx device, this can be accomplished by occluding
the flow divider with the use of a proximal aortic cuff.
Because of the presence of an aneurysmal right common
iliac artery, distal fixation required deployment of an iliac
limb extension landing distally in the right external iliac
artery. The right hypogastric artery was chronically oc-
cluded at baseline. A right to left femoral-femoral bypass
was then constructed to provide contralateral limb perfu-
sion as well as retrograde perfusion to the pelvis via the left
hypogastric artery. A contralateral occluder for the left
common iliac artery was not used because we relied on the
chronic occlusion as a means of protection from retrograde
flow into the sac. Chronic calcified occlusive disease (unlike
acute soft thrombus) at the left common iliac artery oblit-
erated the lumen of the artery. This situation was thought
to be protective against retrograde aneurysm sac pressur-
ization.
focus on fixation zones
t B Patient C Patient D Patient E
23 26 25
38 20 15 (left renal)
60 57 62
0 mm) 13 15 15
ed 14 13 15
smal) No Mild No
ed) No Mild No
; left, patent Patent Patent Patent
rospective three-dimensional reconstructions of CT data
pogastric artery occlusion are noted.ith
atien
25
21
60
IA, 1
cclud
neury
cclud
luded, Ret
ht hy
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A noncontrast CT scan showed the ruptured AAA. The
patient was transported by helicopter to our facility. The
cross-sectional dimensions of the proximal and distal fixa-
tion zones were relayed by phone from the outside medical
center’s radiologist to our vascular surgeon. An endograft
representative was immediately contacted, and the required
endovascular components were ordered. Both patient and
graft arrived simultaneously 2 hours later, and at that time
the patient was hemodynamically stable but had marked ST
segment elevations and tachycardia. After general anesthe-
sia was induced, an arteriogram was obtained, and the neck
length of the aneurysm measured approximately 15 mm
below the left renal artery but was angulated and ulcerated,
with the aneurysm extending to the level of the right renal
artery. After deployment of the endograft, a large type I
endoleak was evident at the right renal artery. This was
repaired with a proximal extension cuff that needed to
Table III. Summary of endograft make and design used fo
Graft-anatomy Patient A P
Endograft type Ancure A
Main body 26  13 28
Iliac extensions Stenotic common iliacs 16
Delivery sheath size 25 French 21
*Modular bifurcated main body was converted to aorto–uni-iliac design by
divider.
Fig 2. Intraoperative arteriograms of patient B. A, Initia
a right common iliac aneurysm. B, Initial deployment of t
C, Conversion to an aorto–uni-iliac system with the
D, Completion arteriogram after femoral-femoral bypaspartially cover the right renal artery for an adequate seal.
Although there was no filling abnormality of the right renal
artery on the completion angiogram, we fully anticipated
this renal artery would thrombose, as was demonstrated by
postoperative renal duplex scanning.
This patient experienced a myocardial infarction, most
likely from pre-existing coronary artery disease plus the
sudden pain and hypovolemia associated with the initial
contained rupture/syncope event. He did well postopera-
tively. However, several days after discharge, he returned to
the emergency department with shortness of breath and
was diagnosed with a pulmonary embolus. He underwent
anticoagulation and was discharged several days later. The
patient then returned 1 month after discharge with a CT
angiogram showing a type II endoleak from the inferior
mesenteric artery. This was embolized via a translumbar
approach and direct sac puncture. He has done well since
with a shrinking aneurysm sac.
A endovascular exclusion
t B Patient C Patient D Patient E
x AneuRx AneuRx AneuRx
6* 26  15 28  16 28  16
1.5 15  11.5 16  11.5 16  11.5
ch 21 French 21 French 21 French
yment of a proximal aortic extension cuff (28  3.75) to occlude the flow
riogram demonstrating left common iliac occlusion and
ft body and retrograde injection of the right iliac system.
of an aortic extension cuff across the flow divider.
8-mm polytetrafluoroethylene.r AA
atien
neuR
 1
 1
Fren
deplol arte
he gra
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outcomes. Overall survival was 100%. The only patient to
have an elevated creatinine level postoperatively was patient
E, which was not unexpected after intentional covering of
the right renal artery to achieve complete proximal seal.
This patient, however, did not require dialysis. Table IV
details the key operative and perioperative measured vari-
ables and outcomes.
DISCUSSION
The routine use of endovascular technology to treat
AAAs is becoming more widespread throughout the world
and is performed in about 50% of elective aneurysm re-
pairs.3 The role of endovascular repair for AAAs with
emergency presentations remains experimental. Overall,
AAA rupture continues to have an associated overall mor-
tality in excess of 80%.7 In this article we report on 5
patients with ruptured AAAs in whom open repair would
have likely been fatal, yet they were successfully treated with
endovascular aneurysm exclusion. With endovascular repair
we achieved 100% survival despite associated severe ad-
vanced pulmonary and cardiac pre-existing comorbidity.
Only 1 patient sustained significant postoperative morbid-
ity but recovered well despite a series of unavoidable com-
plications. Because this patient had an infarct in his myo-
cardium as he arrived at our medical center, it is likely that
he would not have survived open repair. The insult of an
open repair for a ruptured AAA with its associated cross-
clamp on the supraceliac aorta and the bleeding/coagu-
lopathy is usually associated with the disruption of large
retroperitoneal hematoma. We found that 50% of our
ruptures were treated by endovascular means, which is not
the minority, in contrast to what one might have antici-
pated. This is likely because our total number of ruptured
AAA presentations is usually low by virtue of our location
with many nearby excellent medical centers. However, this
number is skewed toward the higher complexity cases by
virtue of our referral patterns.
These 5 patients underwent operation exclusively with
commercially available endografts. No grafts were pre-
stocked as part of our operating room inventory. All en-
dografts required sizing and design based on available
imaging. In some circumstances (for example, in conver-
Table IV. Summary of key measured variables and outcom
Patient A Patient B
Operative blood loss (mL) 350 150
Endograft procurement time (h) 4 3
Operating room time (h) 5 4.5
Creatinine on admission (mg/dL) 1.6 2.4
Creatinine at discharge (mg/dL) 1.3 1.2
Days to tolerating by month diet 4 3
Days to discharge 7 6
Complications Diarrhea
PE, Pulmonary embolus.sion of an AneuRx bifurcated main trunk to an aortouni-
iliac design), these devices were used in an off-label fashion.
These were unique clinical circumstances that prompted us
to push the existing endovascular technology within a zone
that we deemed acceptable on the basis of the specific
clinical situation and our extensive familiarity with the
devices. We hope that future trials will be performed to
evaluate endografts specifically designed for aortic rupture.
However, the aim of this report is to depict the versatility of
our current commercially available devices that can be
successfully used in this fashion in some very specific clinical
settings. The long-term outcome is not yet known. How-
ever, severe pre-existing medical comorbidity was the cen-
tral indication for us to use an endovascular approach rather
than an open approach in these acute presentations. Those
same comorbidities would likely make it difficult to obtain
long-term data or to ever consider the option of bridging to
an open repair.
The anticipated delays one might expect with commer-
cial endograft procurement did not become a logistical
problem, although we would acknowledge that waiting for
the device could provoke anxiety for all involved. However,
if a patient became hemodynamically unstable during the
procurement phase, an open repair would have been per-
formed as a last effort. Our mean graft procurement time
was 3.1 hours, and our patients’ overall procedure-waiting
time was estimated to be between 8 and 24 hours including
transfer time. Waiting for this time period in a patient with
a known AAA rupture might appear unsound. In reference
to different clinical scenarios, some authors contend that
waiting 1.5 to 2 hours for contained retroperitoneal rup-
ture might improve mortality for open repair by allowing
the patient’s condition to stabilize and ensuring proper
imaging.8 Although we are well above that limited delay,
our good outcomes further extend and support the concept
of allowing the patient’s condition to equilibrate and gen-
erating an adequate treatment algorithm in selected cases.
An important concept to implement is to withhold aggres-
sive resuscitation and, in fact, accept mild hypotension
(80-100 mm Hg systolic) that does not result in altered
mental status of the patient. This allows for continued
hematoma containment and affords additional time for
nt C Patient D Patient E Mean
150 125 185
.5 2 2 3.1
.5 4.5 3.5 4.4
.7 0.6 1.1 1.28
.6 0.6 1.9 1.12
3 7 3.6
6 13 6.8
Intraoperative myocardial infarct,
right renal infarct, PE 2 wk
postoperative, endoleak (type II)es
Patie
150
4
4
0
0
1
2
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ment.
It is important to recognize that endograft design
based on intraoperative arteriography alone is suboptimal,
because it is difficult to judge the extent of the aneurysm.
Some form of cross-sectional imaging that can delineate the
diameters of the proximal and distal fixation points and
confirm the infrarenal extent of the aneurysm would be
required. However, our experience has shown that it does
not have to be a thin-cut contrast-enhanced CT angiogram
extending from the hiatus down to the femoral bifurcation.
Although such a Stent graft protocol imaging would be
ideal, it is not an absolute requirement for emergency
endograft design and need not delay prompt repair. As
exemplified by this extended case report, the commercially
available endografts do confer a significant degree of design
flexibility.
Others have adopted protocols for endovascular treat-
ment of ruptured AAAs, reporting improved morbidity and
mortality over historical controls.5,9 The Montefiore
group5 have reported very encouraging results with their
homemade Montefiore Endovascular Grafting System
(MEGS), which consists of a one-size-fits-all aortouniiliac
design supplemented with a femoral-femoral bypass. Be-
cause of the in-house endograft availability, their protocol
allows for the inclusion of patients with free rupture and
hemodynamic instability. In their study, 31 patients pre-
sented with AAA rupture, and 25 underwent endovascular
graft repair. Six patients with unsuitable anatomy required
open repair. Total operative mortality was 9.7% (3 pa-
tients). The advantages of the Montefiore model are the
immediate availability and one-size-fits-all design.
Another group has reported their experience with the
endovascular treatment of ruptured AAAs.10,11 Although
35% mortality was reported, all patients received detailed
contrast-enhanced CT scans regardless of hemodynamic
status. Their group used both bifurcated grafts and aorto-
uniiliac devices. This group seemed to be more tolerant of
operative delay in favor of adequate imaging and a per-
fected preoperative Stent graft design. Although such an
approach might initially seem unjustifiably risky, in fact,
patients with contained retroperitoneal rupture of AAA
might have several hours for perioperative planning. A
report by Walker et al12 demonstrated the natural history of
ruptured AAA untreated. In this retrospective review of
nonoperative cases, they found that patients had a mean life
expectancy of 8 hours from admission with ruptured AAA.
Therefore, we now view each case individually, balancing the
risks of open repair in the setting of significant cardiopulmo-
nary comorbidity versus the risk of any planned delays if an
endovascular approach is considered safer for the patient.
Institutions willing to embark on this mode of therapy
would need to limit it to hemodynamically stable patients
or to establish a method for immediate endograft procure-
ment (ie, stock endografts that would cover a range of
fixation diameters). The ability to convert a bifurcated
system to an aorto–uni-iliac device (ie, with a proximal
extension cuff into the ipsilateral limb) is very importantand should be available. Patients with hemodynamic insta-
bility would rely on intraoperative arteriography for imag-
ing, decision making, and graft design, unless an expedi-
tious protocol for CT scanning (15 minutes total) can be
implemented. Access to the brachial/axillary artery for
supraceliac balloon occlusion can also be a useful adjunct to
have available, as has been previously described by the
Montefiore group. Because all of our patients were hemo-
dynamically stable, we did not use this technique.
This protocol requires a collaborative effort on the part
of emergency department, operating room, radiology per-
sonnel, and company representatives for prompt device
availability. Advance meetings, discussions, and protocol
development within these vital operational components are
imperative to ensure timely execution of this treatment
algorithm. We found through this experience that a se-
lected stock inventory would serve an expeditious route for
treating these patients. Our data would suggest that 2
larger diameter main bodies along with ample accessory
components (extensions) and limb diameters would suffice.
It is currently difficult to predict whether endografts capa-
ble of handling more complex anatomy would have in-
creased the number of patients in this limited series. In
addition, without stocking at least the 2 most commonly
used sizes of these endografts and a variety of the required
ancillary components, it is likely that the reported treat-
ment algorithm would by necessity be relegated to large
referral areas in which clinical specialists can “pirate” de-
vices from one hospital to supply another in the setting of
an emergency.
Mortality rates for ruptured AAA have remained rela-
tively high despite advances in diagnostic modalities and
postoperative care.13 We believe these 5 cases support the
consideration of a novel treatment protocol for ruptured
AAA, utilizing the option of commercially available en-
dografts. By demonstrating that patients with extreme co-
morbidities can survive AAA rupture by using endovascular
repair, we propose that other centers that perform high
volume endovascular AAA repair can broaden their arma-
mentarium to aid in treatment and potentially improve
outcome in this difficult patient population.
REFERENCES
1. Collin J, Murie JA. Endovascular treatment of abdominal aortic aneu-
rysm: a failed experiment. Br J Surg 2001;88:1281-2.
2. Hinchcliffe RJ, Wenham PW, Hopkinson BR. Endovascular treatment
of abdominal aortic aneurysm: a failed experiment. Br J Surg 2002;89:
498; author reply 500-1.
3. Bertrand M, Godet G, Koskas F, Cluzel P, Fleron MH, Kieffer E, et al.
Endovascular treatment of abdominal aortic aneurysms: is there a
benefit regarding postoperative outcome? Eur J Anaesthesiol 2001;18:
245-50.
4. Walschot LH, Laheij RJ, Verbeek AL. Outcome after endovascular
abdominal aortic aneurysm repair: a meta-analysis. J Endovasc Ther
2002;9:82-9.
5. Ohki T, Veith FJ. Endovascular therapy for ruptured abdominal aortic
aneurysms. Adv Surg 2001;35:131-51.
6. Ohki T, Veith FJ. Endovascular grafts and other image-guided catheter-
based adjuncts to improve the treatment of ruptured aortoiliac aneu-
rysms. Ann Surg 2000;232:466-79.
JOURNAL OF VASCULAR SURGERY
July 2004160 Lombardi et al7. Taylor LM Jr, Porter JM. Basic data related to clinical decision-making
in abdominal aortic aneurysms. Ann Vasc Surg 1987;1:502-4.
8. Mackiewicz Z, Molski S, Szpinda M, et al. Retroperitoneal rupture of
abdominal aortic aneurysms. J Mal Vasc 1998;23:368-70.
9. Greenberg RK, Srivastava SD, Ouriel K, Waldman D, Ivancev K, Illig K,
et al. An endoluminal method of hemorrhage control and repair of
ruptured abdominal aortic aneurysms. J Endovasc Ther 2000;7:1-7.
10. Hinchliffe RJ, Yusuf SW, Macierewicz JA, MacSweeney ST, Wenham
PW, et al. Endovascular repair of ruptured abdominal aortic aneu-
rysm: a challenge to open repair? results of a single centre experience
in 20 patients. Eur J Vasc Endovasc Surg 2001;22:528-34.11. Hinchliffe RJ, Hopkinson BR. Ruptured abdominal aortic aneurysm:
time for a new approach. J Cardiovasc Surg (Torino) 2002;43:345-7.
12. Walker EM, Hopkinson BR, Makin GS. Unoperated abdominal aortic
aneurysm: presentation and natural history. Ann R Coll Surg Engl
1983;65:311-3.
13. Heller JA, Weinberg A, Arons R, Krishnasastry KV, Lyon RT, Deitch
JS, et al. Two decades of abdominal aortic aneurysm repair: have we
made any progress? J Vasc Surg 2000;32:1091-100.
Submitted Oct 14, 2003; accepted Feb 26, 2004.
Available online May 24, 2004.
